---
title: CROs offering In Vitro ADME / DMPK with Cell Therapy
path: /explore/in-vitro-admet/cell-therapy
companies_count: 21
---

# CROs offering In Vitro ADME / DMPK with Cell Therapy

21 published CROs match In Vitro ADME / DMPK and Cell Therapy.

Locations in this set include United States, China, India, Germany, Netherlands, and United Kingdom.

Capabilities that show up most often in this set: Preclinical In Vitro Studies, In Vitro Pharmacology, In Vivo PK / PD Studies, Preclinical In Vivo Studies, and Bioanalysis.

## Matching companies

- [Altasciences](/companies/altasciences)
  - Mid-size early phase CRO/CDMO in Canada and the U.S. offering preclinical safety testing, clinical pharmacology (Phase I–II), bioanalysis, research services, and manufacturing with integrated capabilities.
- [Aragen Life Sciences](/companies/aragen)
  - Global CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe.
- [Certara](/companies/certara)
  - Certara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making.
- [Creative Bioarray](/companies/creative-bioarray)
  - Creative Bioarray provides preclinical research solutions including drug screening, ADME-PK, toxicity studies, and cell-based services across oncology, neurology, cardiovascular, and metabolic therapeutic areas.
- [Crown Bioscience](/companies/crownbio)
  - Preclinical oncology CRO offering 2,500+ PDX models, organoid and cell line databases, and translational platforms with biomarker discovery and AI-driven systems biology for drug development.
- [Frontage Laboratories](/companies/frontagelab)
  - Global pharmaceutical development organization offering integrated drug discovery, preclinical safety/toxicology, DMPK, bioanalytical, and clinical trial services across 28 sites with 2,200 employees and 200+ FDA inspections.
- [JangoCell](/companies/jangocell)
  - JangoCell provides contract cell expansion, flow cytometry, cell sorting, and molecular biology services for researchers, with expertise in both 2D and 3D bioreactor-based culture systems scaling to billions of cells.
- [Labcorp](/companies/labcorp)
  - Labcorp is a global life sciences and healthcare company providing diagnostic testing, drug development, nonclinical research, central laboratory services, and real-world data solutions to healthcare providers, health systems, and biopharma companies.
- [Medpace](/companies/medpace)
  - Full-service CRO with 30+ years of organic growth, offering integrated clinical development services across all phases with wholly-owned central labs, bioanalytical lab, imaging core lab, and Phase I unit.
- [NorthEast BioLab](/companies/nebiolab)
  - Bioanalytical CRO providing PK/PD, immunogenicity (ADA/nAb), cytokine, and biomarker assays across LC-MS, Meso Scale Discovery, ELISA, and ddPCR platforms. Operates GLP/GCLP-compliant facilities and reports DEA and CT approval for Schedule I–IV bioanalysis.
- [Pharmaron](/companies/pharmaron)
  - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
- [Premier Research](/companies/premier-research)
  - Premier Research is a global full-service CRO delivering clinical research and development solutions across the complete drug development lifecycle. The organization provides comprehensive capabilities spanning study design, study startup, medical affairs, biostatistics and data management, central monitoring, clinical monitoring and site management, project and risk management, safety and pharmacovigilance, quality and compliance, and medical writing.
- [Proone Labs](/companies/proonelabs)
  - Proone Labs provides preclinical pharmacology, drug discovery, and regulatory support services to biotech startups, traditional pharma, and in-silico companies. The team has delivered 30+ assays, 50+ cell lines, and supported 4 FDA drug approvals across multiple therapeutic areas.
- [Protheragen](/companies/obesityscientific)
  - Specialized preclinical CRO dedicated to obesity research, offering comprehensive animal models, pharmacokinetic/pharmacodynamic studies, bioanalysis, and safety assessment for anti-obesity drug development.
- [QPS](/companies/qps)
  - QPS provides integrated contract research and clinical services spanning bioanalysis, preclinical development, and early-to-late phase clinical trials across multiple therapeutic areas including oncology, dermatology, and women's health.
- [Reaction Biology](/companies/reactionbiology)
  - Global preclinical CRO specializing in kinase drug discovery, cell-based assays, in vivo pharmacology, and immuno-oncology with 1,000+ cell lines and hundreds of validated protein targets across US and EU facilities.
- [STEMCELL Technologies Inc.](/companies/stemcell)
  - STEMCELL Technologies develops and sells cell culture media, cell separation systems, instruments, and reagents for life sciences research, plus contract research services including biopharmaceutical testing, cell characterization, toxicity testing, and organoid assays.
- [Sannova](/companies/sannova)
  - Sannova provides bioanalytical and analytical CRO services, including immunogenicity and ligand binding assays, PK testing, DMPK services, extractables and leachables, nitrosamine testing, and pharmaceutical stability testing. Its listed work spans small molecules, biologics and biosimilars, and cell and gene therapies.
- [Syngene International](/companies/syngeneintl)
  - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
- [Tigermed](/companies/tigermedgrp)
  - Leading global CRO providing end-to-end clinical trial services, preclinical development, medical device and IVD trials, regulatory affairs, and real-world evidence studies across 180+ offices serving 4,000+ customers.
